<DOC>
	<DOCNO>NCT01288651</DOCNO>
	<brief_summary>Patients idiopathic pulmonary arterial hypertension ( IPAH ) iron deficiency previously show decreased six-minute walking distance . Therefore investigator hypothesize intravenous iron administration would improve exercise capacity iron deficient IPAH patient . 30 patient recruit iron infusion . At baseline 12 week ( endpoint ) exercise test perform .</brief_summary>
	<brief_title>Iron Deficiency In Pulmonary Hypertension</brief_title>
	<detailed_description>Background : Patients pulmonary arterial hypertension ( PAH ) develop progressive right heart failure eventually lead death . During progression disease physical performance patient deteriorate . Maintaining exercise capacity major goal PAH treatment . Iron treatment know positive effect physical performance patient leave heart failure iron deficiency . Whether also effective patient right heart failure ( PAH ) iron deficiency unknown . Objective : To evaluate effect intravenous iron supplementation exercise capacity iron deficient IPAH patient . Study design : Intervention study Study population : Patients idiopathic pulmonary arterial hypertension ( IPAH ) iron deficiency Patients receive iron bolus infusion 1000 mg iron baseline measurement . Main study parameters/endpoints : Primary endpoint : six minute walk distance ( 6WMD ) Secondary endpoint : cardiopulmonary exercise test , myoglobin concentration quadriceps muscle , quadriceps muscle fiber strength , serum iron parameter , serum inflammatory parameter , quality life ( QOL ) , NYHA functional class . The patient hospitalise two day begin two day end study perform exercise strength test , six minute walk distance biopsy quadriceps muscle . Also NYHA functional class determine QOL questionnaire fill . After baseline measurement iron infusion give ( Ferinject 1000mg ) . The investigator hypothesize iron deficient IPAH patient benefit iron treatment improve exercise capacity reflect increase 6MWD .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
	<mesh_term>Iron</mesh_term>
	<criteria>Stable idiopathic pulmonary arterial hypertension ( stable disease least 3 month ) iron deficiency ( serum iron 10 μmol/l , decrease transferrin saturation ( &lt; 15 % female &lt; 20 % male ) serum ferritin &lt; 100 μg/l ) irrespective coexistence anaemia Current iron therapy ( oral iv ) Current study medication PAH History anaemia current treatment anaemia Liver function impairment Chronic disease PAH ( rheumatism , asthma , chronic infection ) Acute infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2011</verification_date>
	<keyword>Pulmonary arterial hypertension</keyword>
	<keyword>Iron deficiency</keyword>
	<keyword>Exercise</keyword>
</DOC>